CTNB1 AS A MARKER FOR ENDOMETRIAL CANCER
Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-acces isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples.The invention also provides kits comprising means for detecting said proteins...
Saved in:
| Main Authors | , , , , , , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
24.01.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-acces isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples.The invention also provides kits comprising means for detecting said proteins for use in the diagnosis and prognosis of the disease.
La présente invention concerne une méthode de diagnostic et de pronostic du cancer de l'endomètre dans des échantillons isolés faciles d'accès par détection du niveau d'expression d'une ou de plusieurs protéines. En particulier, provenant d'échantillons de fluide utérin. L'invention concerne également des kits comprenant des moyens pour détecter lesdites protéines pour une utilisation dans le diagnostic et le pronostic de la maladie. |
|---|---|
| AbstractList | Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-acces isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples.The invention also provides kits comprising means for detecting said proteins for use in the diagnosis and prognosis of the disease.
La présente invention concerne une méthode de diagnostic et de pronostic du cancer de l'endomètre dans des échantillons isolés faciles d'accès par détection du niveau d'expression d'une ou de plusieurs protéines. En particulier, provenant d'échantillons de fluide utérin. L'invention concerne également des kits comprenant des moyens pour détecter lesdites protéines pour une utilisation dans le diagnostic et le pronostic de la maladie. |
| Author | MARTINEZ GARCIA, ELENA DOMON, BRUNO REVENTOS PUIGJANER, JAUME COLAS ORTEGA, EVA CAMPOY MONCAYO, IRENE GIL MORENO, ANTONIO LESUR, ANTOINE |
| Author_xml | – fullname: LESUR, ANTOINE – fullname: MARTINEZ GARCIA, ELENA – fullname: DOMON, BRUNO – fullname: GIL MORENO, ANTONIO – fullname: CAMPOY MONCAYO, IRENE – fullname: COLAS ORTEGA, EVA – fullname: REVENTOS PUIGJANER, JAUME |
| BookMark | eNrjYmDJy89L5WTQcA7xczJUcAxWcFTwdQzydg1ScPMPUnD1c_H3dQ0J8nT0UXB29HN2DeJhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjsYG5gYGJoaOhsZEKAEAYxQkpw |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences Physics |
| DocumentTitleAlternate | CTNB1 UTILISE EN TANT QUE MARQUEUR POUR LE CANCER DE L'ENDOMETRE |
| ExternalDocumentID | CA3070041A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CA3070041A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:06:07 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CA3070041A13 |
| Notes | Application Number: CA20183070041 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190124&DB=EPODOC&CC=CA&NR=3070041A1 |
| ParticipantIDs | epo_espacenet_CA3070041A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20190124 |
| PublicationDateYYYYMMDD | 2019-01-24 |
| PublicationDate_xml | – month: 01 year: 2019 text: 20190124 day: 24 |
| PublicationDecade | 2010 |
| PublicationYear | 2019 |
| RelatedCompanies | FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON-INSTITUT DE RECERCA LUXEMBOURG INSTITUTE OF HEALTH (LIH) INSTITUT DE RECERCA BIOMEDICA DE LLEIDA FUNDACIO DR PIFARRE |
| RelatedCompanies_xml | – name: INSTITUT DE RECERCA BIOMEDICA DE LLEIDA FUNDACIO DR PIFARRE – name: FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON-INSTITUT DE RECERCA – name: LUXEMBOURG INSTITUTE OF HEALTH (LIH) |
| Score | 3.184137 |
| Snippet | Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-acces isolated samples by detecting the level of expression of... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING |
| Title | CTNB1 AS A MARKER FOR ENDOMETRIAL CANCER |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190124&DB=EPODOC&locale=&CC=CA&NR=3070041A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5Kfd40KtYXe5DgJZhnJYcgm01CfSQpMUpvpZtuoJdaTMS_7-ySVi96nYV9DDsz-83OA-Da4kI4dm2h9hO-4Q5rYfjcrgyOiMV3-Kz2VI-lNBuOXt3HiTfpwWKdC6PqhH6p4ogoURXKe6v09erHiRWp2Mrmli-Q9H6flEGkd-hYWjfb1aMwiMd5lDOdsYBRPSsCebVN16IIlLbwFX0nhSF-C2VSyuq3RUkOYHuMky3bQ-iJpQZ7bN14TYPdtPvv1mBHBWhWDRI7IWyO4IaVWWgR-kIoSWnxFBcEoRyJsyhP47J4oM-EyZYzxTGQJC7ZyMDFp5uDThndbNM5gT7if3EKxBe-LararASaYmQtR_Vk8tqZ296smjn1AAZ_TnP2z9g57EuOSX-C7V5Av_34FJdoYVt-pXjzDSyYeyY |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLam8Rg3KCDGMwdUcalYHxvqoUJZ2qpjfUyloN2mpaTSLmNiRfx9nKgbXODqSHlYsZ3P8QPg1uRC2FZlovYTruEMKmG43CoNjojFtfm86qseS0k6iF6cp2l_2oLFJhdG1Qn9UsURUaJKlPda6evVjxPLV7GV63u-QNL7Y1h4vt6gY2ndLEf3h14wyfyM6Yx5jOpp7smr3XNMikBpB1_YD1IYgtehTEpZ_bYo4SHsTnCyZX0ELbHUoMM2jdc02E-a_24N9lSAZrlGYiOE62O4Y0U6NAl9JpQkNB8HOUEoR4LUz5KgyEc0Jky2nMlPgIRBwSIDF59tDzpjdLtN-xTaiP_FGRBXuJYoq14p0BQjazmqpx6v7DerPy_ndtWF7p_TnP8zdgOdqEjiWTxKxxdwILknfQuWcwnt-uNTXKG1rfm14tM3HiB-GQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CTNB1+AS+A+MARKER+FOR+ENDOMETRIAL+CANCER&rft.inventor=LESUR%2C+ANTOINE&rft.inventor=MARTINEZ+GARCIA%2C+ELENA&rft.inventor=DOMON%2C+BRUNO&rft.inventor=GIL+MORENO%2C+ANTONIO&rft.inventor=CAMPOY+MONCAYO%2C+IRENE&rft.inventor=COLAS+ORTEGA%2C+EVA&rft.inventor=REVENTOS+PUIGJANER%2C+JAUME&rft.date=2019-01-24&rft.externalDBID=A1&rft.externalDocID=CA3070041A1 |